Back to Feed
Fintech
Bicara Therapeutics Announces Inducement Grant under Nasdaq
Globenewswire·
BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing...
Original Source
Globenewswire — www.globenewswire.com